| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Common shares without par value | 211K | $22.1M | $104.57 | 10 May 2024 | Direct |
| ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Common shares without par value | 20K | $2.09M | $104.57 | 10 May 2024 | By Trust |
| ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Common shares without par value | 18.8K | $1.96M | $104.57 | 10 May 2024 | Profit Sharing Trust |
| ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Common shares without par value | 500 | $52.3K | $104.57 | 10 May 2024 | By Daughter |
| ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Option (right to buy) | 45K | 10 May 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 10 May 2024 | 3 | -$581K | 4 | EXECUTIVE VICE PRESIDENT | 14 May 2024, 17:35 |
| ABT | ABBOTT LABORATORIES | 29 Feb 2024 | 1 | -$1.37M | 4 | EXECUTIVE VICE PRESIDENT | 04 Mar 2024, 19:00 |
| ABT | ABBOTT LABORATORIES | 21 Feb 2024 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 23 Feb 2024, 17:29 |
| ABT | ABBOTT LABORATORIES | 13 Sep 2023 | 3 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 15 Sep 2023, 17:35 |
| ABT | ABBOTT LABORATORIES | 28 Feb 2023 | 2 | -$1.27M | 4 | EXECUTIVE VICE PRESIDENT | 02 Mar 2023, 18:35 |
| ABT | ABBOTT LABORATORIES | 17 Feb 2023 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 22 Feb 2023, 17:53 |
| ABT | ABBOTT LABORATORIES | 28 Feb 2022 | 1 | -$1.32M | 4 | EXECUTIVE VICE PRESIDENT | 02 Mar 2022, 18:44 |
| ABT | ABBOTT LABORATORIES | 18 Feb 2022 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 23 Feb 2022, 19:12 |